Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion type Assertion NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_head.
- NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion description "[In addition to eotaxin-1 expression, but also eotaxin-2 and eotaxin-3 expression in the bronchial epithelium should be taken into consideration when developing the therapeutic strategies to treat eosinophilic airway diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_provenance.
- NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion evidence source_evidence_literature NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_provenance.
- NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion SIO_000772 14698143 NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_provenance.
- NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion wasDerivedFrom befree-20150227 NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_provenance.
- NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_assertion wasGeneratedBy ECO_0000203 NP841177.RAKGUccpMa1zqMdoSvwk9HRqu__69I_xU243Yi3MbJQ6I130_provenance.